Table 2 Univariate and multivariate Cox models of DFS for different variables and rs2234693.

From: The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival

DFS

Frequency

Univariate

Multivariate

HR

95% CI

P value

HR

95% CI

P value

Age

805

0.997

0.980–1.015

0.763

   

BMI

805

0.984

0.951–1.019

0.360

   

T stage

T1

367 (45.7)

      

T2-4

436 (54.3)

2.002

1.434–2.796

0.00005

1.833

1.258–2.671

0.002

N stage

N0

237 (29.5)

      

N + 

566 (70.5)

1.198

0.842–1.704

0.315

   

PR status

Positive

590 (77.1)

      

Negative

175 (22.9)

1.684

1.198–2.367

0.003

1.716

1.120–2.434

0.002

Histological grade (BR)

1

143 (18.7)

1.000

 

0.094*

1.000

 

0.150*

2

369 (48.4)

1.712

1.038–2.824

 

1.673

0.989–2.831

 

3

251 (32.9)

1.691

1.002–2.854

 

1.621

0.931–2.821

 

Most extensive surgery

Wide local excision

372 (46.2)

      

Mastectomy

433 (53.8)

1.742

1.258–2.413

0.001

1.527

1.057–2.206

0.024

Adjuvant chemotherapy

No

589 (74.3)

      

Yes

216 (26.8)

0.969

0.677–1.387

0.865

   

Adjuvant radiotherapy

No

487 (60.5)

      

Yes

318 (39.5)

0.846

0.619–1.156

0.294

   

rs2234693 (ESR1, PvuII)

CC

149 (18.4)

1.000

 

0.105*

   

CT

361 (51.1)

0.656

0.445–0.969

    

TT

200 (28.1)

0.751

0.487–1.158

    

CC

149 (21.0)

1.000

  

1.000

  

TT/CT

561 (79.0)

0.689

0.480–0.989

0.044

0.696

0.469–1.031

0.071

  1. DFS, disease free survival; HR, hazard ratio; CI, confidence interval; BMI, body mass index; PR, progesterone receptor; BR, Bloom Richardson. The multivariate analysis is compensated for T stage, PR status, histological grade, and type of surgery. Bold values indicate P < 0.05. *Global P-value.